Eletriptan Hydrobromide
Product Images NDC 27241-039

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Eletriptan Hydrobromide (NDC 27241-039). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Eletriptan 20mg

Eletriptan Hydrobromide Tablets 20 mg carton packaging from Ajanta Pharma USA Inc. The label shows the product name, strength, and tablet count (6 unit dose tablets). It includes storage instructions and states the product is made in India. The packaging also features the NDC 27241-039-11 and marks the product for prescription use only.*

FDA Label Image

Eletriptan 40mg

Packaging label for Eletriptan Hydrobromide Tablets, 40 mg, by Ajanta Pharma USA Inc. The label indicates prescription-only status, contains storage instructions, and notes the product is marketed by Ajanta Pharma USA Inc. in Bridgewater, NJ, made in India. The package design includes wave graphics and displays NDC 27241-040-11 with a barcode on the side.*

FDA Label Image

Fig_1 (Eletriptan Fig1)

A line graph titled 'Estimated Probability of Initial Headache Response Within 2 Hours' displaying estimated probability of response over time (0 to 2 hours) from initial dose. It compares double blind placebo and eletriptan at doses of 20 mg, 40 mg, and 80 mg, showing increased probability of response with higher eletriptan doses versus placebo.*

FDA Label Image

Fig_2 (Eletriptan Fig2)

A line graph showing the estimated probability of taking a second dose or other medication over 24 hours following the first dose. It compares placebo, and eletriptan at 20 mg, 40 mg, and 80 mg doses, plotted against time in hours from the initial dose.*

FDA Label Image

Str (Eletriptan Str)

Chemical structure of eletriptan hydrobromide showing its molecular arrangement with a sulfonyl group attached to an indole ring and a pyrrolidine ring, along with the hydrobromide salt component (HBr).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.